The short version
Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Sodium acetate anhydrous
Sodium acetate anhydrous · SODIUM ACETATE ANHYDROUS 164 mg/mL · Solution, Concentrate · Intravenous · Somerset Therapeutics, LLC
NDC 70069-0047-25 · 25 VIAL, GLASS in 1 CARTON / 50 mL in 1 VIAL, GLASS · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$200.00
Reported to Texas DSHS · 2026 annual filing · Somerset Therapeutics, LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2026 YTD · Q1)ⓘ
$8,489
14 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA219826
- TE code
- AP
- Approval date
- Sep 18, 2025
- Patents / exclusivity
- None on file
Shortage history
- In shortage now — Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25)Feb 3, 2016month 127 — 11× the typical 12-month other shortage
- In shortage now — Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20)Feb 3, 2016month 127 — 11× the typical 12-month other shortage
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Sodium acetate anhydrous (Solution, Concentrate)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Somerset Therapeutics, LLC | SODIUM ACETATE ANHYDROUS 164 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Sodium acetate anhydrous — NDC 70069-0047-25," retrieved September 3, 2026, https://drugdashboards.com/drug/70069004725.
Free to cite with attribution — see how the data is put together.